Developing mitochondrial small molecule drugs for difficult to treat neurological diseases.
Neuroene Therapeutics is a pioneering biotechnology research company dedicated to developing innovative solutions for challenging neurological diseases. Located in Washington, D.C., at its primary address of 7144 13th Pl NW, Washington, District of Columbia 20012, US, Neuroene Therapeutics is focused on creating mitochondrial small molecule drugs. These drugs hold immense potential for treating conditions that have historically been difficult to manage.
Neuroene Therapeutics' mission is to improve the lives of individuals affected by severe neurological disorders. The company specializes in addressing conditions such as Dravet Syndrome, Epilepsy, and Parkinson's Disease through targeted mitochondrial therapies. Neuroene Therapeutics is committed to advancing scientific understanding and translating research breakthroughs into effective treatments.
Neuroene Therapeutics' innovative approach and dedication to scientific excellence position it as a key player in the biotechnology landscape. We invite the management of Neuroene Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.
Neuroene Therapeutics est une entreprise pionnière de recherche biotechnologique dédiée au développement de solutions innovantes pour les maladies neurologiques difficiles à traiter. Située à Washington, D.C., à son adresse principale au 7144 13th Pl NW, Washington, District of Columbia 20012, US, Neuroene Therapeutics se concentre sur la création de médicaments à petites molécules mitochondriales. Ces médicaments recèlent un immense potentiel pour traiter des affections qui ont été historiquement difficiles à gérer.
La mission de Neuroene Therapeutics est d'améliorer la vie des personnes touchées par des troubles neurologiques graves. L'entreprise se spécialise dans la lutte contre des affections telles que le syndrome de Dravet, l'épilepsie et la maladie de Parkinson grâce à des thérapies mitochondriales ciblées. Neuroene Therapeutics s'engage à faire progresser la compréhension scientifique et à traduire les découvertes de la recherche en traitements efficaces.
L'approche innovante de Neuroene Therapeutics et son dévouement à l'excellence scientifique la positionnent comme un acteur clé dans le paysage biotechnologique. Nous invitons la direction de Neuroene Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'amplifier davantage leur portée et leur impact.
Compare Neuroene Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Neuroene TherapeuticsMain Company |
Bionics InstituteView Profile |
Brain Research Found...View Profile |
First Choice Neurolo...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1986 | 1953 | 2003 |
|
Company Size
|
— | 51-200 | 2-10 | 501-1,000 |
|
City
|
Washington, District of Columbia | East Melbourne, Victoria | Chicago, Illinois | Medley, Florida |
|
Country
|
United States | Australia | United States | |
|
Skills & Keywords
Comparing with main company
|
8 Total Skills
Biotechnology
Neurological Diseases
Mitochondrial Drugs
Dravet Syndrome
Epilepsy
Parkinson's Disease
Pharmaceuticals
Mitochondria
|
16 Total
16 Unique
Unique Skills:
Artificial Intelligence
Biomedical engineering
Bionic Vision
Brain Signalling
Contract Research
Crohn's Disease
+10
|
13 Total
13 Unique
Unique Skills:
Addiction
Alzheimer's Disease
Autism
Brain Research
Brain Tumor
Dementia
+7
|
30 Total
30 Unique
Unique Skills:
ADHD
Alzheimer’s Disease
Autism
Brain Injuries
Cannabis Medical Treatment
Clinical Trials
+24
|
Other organizations in the same industry
This company is also known as